Stordahl Capital Management, Inc. Pfizer Inc Transaction History

Stordahl Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $361 - $417	10 Added 0.15%	6,788 $248,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $38,287 - $49,844	972 Added 16.74%	6,778 $276,000
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $4,280 - $5,075	-92 Reduced 1.56%	5,806 $304,000
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $81,572 - $101,078	1,783 Added 43.33%	5,898 $305,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $170,031 - $252,043	4,115 New	4,115 $243,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Stordahl Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Stordahl Capital Management, Inc. with notifications on news.